|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.40 USD | +0.09% |
|
+1.33% | +22.19% |
| 06-16 | CEO moves between industries | RE |
| 06-11 | LiveRamp, Walgreens Advertising Group Partner on Data Collaboration | MT |
| Capitalization | 9.86B 8.51B 8B 7.25B 13.37B 847B 15.09B 93.26B 36.35B 388B 37B 36.22B 1,421B | P/E ratio 2025 * |
-2.93x | P/E ratio 2026 * | -36.8x |
|---|---|---|---|---|---|
| Enterprise value | 16.15B 13.93B 13.1B 11.88B 21.9B 1,387B 24.71B 153B 59.52B 636B 60.58B 59.31B 2,327B | EV / Sales 2025 * |
0.11x | EV / Sales 2026 * | 0.11x |
| Free-Float |
60.68% | Yield 2025 * |
5.81% | Yield 2026 * | 5.2% |
More valuation ratios
* Estimated data
More news
Last Transcript: Walgreens Boots Alliance, Inc.
More recommendations
More press releases
More news
| 1 day | +0.09% | ||
| 1 week | +1.33% | ||
| Current month | +1.33% | ||
| 1 month | +1.97% | ||
| 3 months | +1.51% | ||
| 6 months | +9.72% | ||
| Current year | +22.19% |
| 1 week | 11.32 |  | 11.42 |
| 1 month | 11.1 | | 11.42 |
| Current year | 9.07 | | 13.25 |
| 1 year | 8.08 | | 16.25 |
| 3 years | 8.08 | | 42.74 |
| 5 years | 8.08 | | 57.05 |
| 10 years | 8.08 | | 97.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2023-10-22 | |
Manmohan Mahajan
DFI | Director of Finance/CFO | 46 | 2023-07-26 |
Neal Sample
CTO | Chief Tech/Sci/R&D Officer | 50 | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefano Pessina
CHM | Chairman | 84 | 2021-03-14 |
Jan Babiak
BRD | Director/Board Member | 67 | 2012-03-31 |
| Director/Board Member | 70 | 2006-09-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.09% | +1.33% | -26.69% | -72.01% | 9.86B | ||
| -0.59% | +2.06% | +71.28% | -22.27% | 17.26B | ||
| -1.47% | +0.64% | +36.23% | +0.64% | 9.79B | ||
| -0.74% | -0.56% | +31.43% | +75.20% | 7.87B | ||
| -3.43% | -4.52% | +17.14% | +24.26% | 4.86B | ||
| -0.32% | -0.32% | -4.84% | -15.00% | 4.39B | ||
| -1.12% | -5.93% | -15.27% | -10.81% | 4.18B | ||
| -0.59% | -1.12% | +26.74% | +7.88% | 3.66B | ||
| -8.18% | -6.32% | -34.40% | +74.92% | 2.9B | ||
| +0.06% | -5.79% | -6.06% | -28.70% | 2.58B | ||
| Average | -1.69% | -1.09% | +9.56% | +3.41% | 6.74B | |
| Weighted average by Cap. | -1.22% | +0.39% | +23.01% | -4.72% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 152B 131B 123B 111B 206B 13,022B 232B 1,433B 559B 5,966B 569B 557B 21,839B | 154B 133B 125B 113B 209B 13,222B 235B 1,455B 567B 6,057B 577B 565B 22,174B |
| Net income | -3.36B -2.9B -2.72B -2.47B -4.55B -289B -5.14B -31.77B -12.38B -132B -12.6B -12.34B -484B | -453M -391M -367M -333M -614M -38.9B -693M -4.28B -1.67B -17.82B -1.7B -1.66B -65.24B |
| Net Debt | 6.29B 5.42B 5.1B 4.62B 8.52B 540B 9.62B 59.46B 23.17B 247B 23.59B 23.09B 906B | 6.84B 5.91B 5.55B 5.03B 9.28B 588B 10.47B 64.73B 25.23B 269B 25.68B 25.14B 986B |
More financial data
* Estimated data
Employees
252,500
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-16 | 11.40 $ | +0.09% | 4,424,875 |
| 25-06-13 | 11.39 $ | +0.26% | 6,887,287 |
| 25-06-12 | 11.36 $ | +0.18% | 3,586,225 |
| 25-06-11 | 11.34 $ | -0.09% | 3,724,043 |
| 25-06-10 | 11.35 $ | +0.18% | 7,114,361 |
Delayed Quote Nasdaq, June 16, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
11.40USD
Average target price
12.41USD
Spread / Average Target
+8.89%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WBA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition